Zobrazeno 1 - 10
of 158
pro vyhledávání: '"Gebhard DF"'
Autor:
Hoffman AF; 1 GlaxoSmithKline , Collegeville, Pennsylvania., Nolan J; 2 The Scintillon Institute , San Diego, California., Gebhard DF; 3 Pfizer, Inc. , Groton, Connecticut., Nickischer D; 3 Pfizer, Inc. , Groton, Connecticut., Omta W; 4 Core Life Analytics B.V. , Utrecht, The Netherlands ., Cooper S; 5 Imperial College London, Institute of Cancer Research , London, United Kingdom ., Presnell S; 6 Organovo, Inc. & Samsara Sciences, Inc. , San Diego, California., Wardwell-Swanson J; 7 InSphero, Inc. , Brunswick, Maine., Fennell M; 8 Memorial Sloan Kettering Cancer Center , New York, New York.
Publikováno v:
Assay and drug development technologies [Assay Drug Dev Technol] 2018 Jan; Vol. 16 (1), pp. 1-6.
Autor:
Esaki, Tsuyoshi1,2 (AUTHOR) tsuyoshi-esaki@biwako.shiga-u.ac.jp, Yonezawa, Tomoki3 (AUTHOR), Ikeda, Kazuyoshi3,4 (AUTHOR)
Publikováno v:
Journal of Cheminformatics. 3/14/2024, Vol. 16 Issue 1, p1-11. 11p.
Autor:
Nomura, Teiko Komori1 (AUTHOR), Endo, Satoshi2,3 (AUTHOR), Kuwano, Takuma4 (AUTHOR), Fukasawa, Kazuya5 (AUTHOR), Takashima, Shigeo1,3,6,7 (AUTHOR), Todo, Tomoki8 (AUTHOR), Furuta, Kyoji1,9 (AUTHOR), Yamamoto, Takuhei1,3,4 (AUTHOR), Hinoi, Eiichi1,3,5 (AUTHOR), Koyama, Hiroko1,9 (AUTHOR), Honda, Ryo1,3 (AUTHOR) ryohonda.rh@gmail.com
Publikováno v:
Scientific Reports. 7/4/2023, Vol. 13 Issue 1, p1-11. 11p.
Autor:
Michaud NR; Pfizer Global Research and Development, Groton, CT, USA. neil.michaud@astrazeneca.com, Jani JP, Hillerman S, Tsaparikos KE, Barbacci-Tobin EG, Knauth E, Putz H Jr, Campbell M, Karam GA, Chrunyk B, Gebhard DF, Green LL, Xu JJ, Dunn MC, Coskran TM, Lapointe JM, Cohen BD, Coleman KG, Bedian V, Vincent P, Kajiji S, Steyn SJ, Borzillo GV, Los G
Publikováno v:
MAbs [MAbs] 2012 Nov-Dec; Vol. 4 (6), pp. 710-23. Date of Electronic Publication: 2012 Sep 24.
Autor:
Bagi CM; Worldwide Comparative Medicine, GS&T, Groton, Connecticut, USA. cedo.bagi@pfizer.com, Gebhard DF, Andresen CJ
Publikováno v:
European journal of gastroenterology & hepatology [Eur J Gastroenterol Hepatol] 2012 May; Vol. 24 (5), pp. 563-74.
Autor:
Di L; Pharmacokinetics, Dynamics and Metabolism, Pfizer Inc., Groton, Connecticut, USA. li.di@pfizer.com, Whitney-Pickett C, Umland JP, Zhang H, Zhang X, Gebhard DF, Lai Y, Federico JJ 3rd, Davidson RE, Smith R, Reyner EL, Lee C, Feng B, Rotter C, Varma MV, Kempshall S, Fenner K, El-Kattan AF, Liston TE, Troutman MD
Publikováno v:
Journal of pharmaceutical sciences [J Pharm Sci] 2011 Nov; Vol. 100 (11), pp. 4974-85. Date of Electronic Publication: 2011 Jul 15.
Autor:
Nadanaciva S; Compound Safety Prediction, Worldwide Medicinal Chemistry, Pfizer Inc., Groton, Connecticut, USA., Murray J, Wilson C, Gebhard DF, Will Y
Publikováno v:
Current protocols in toxicology [Curr Protoc Toxicol] 2011 May; Vol. Chapter 3, pp. Unit3.11.
Autor:
Nadanaciva S; Compound Safety Prediction, Worldwide Medicinal Chemistry, Pfizer Inc., Groton, CT 06340, USA. sashi.nadanaciva@pfizer.com, Lu S, Gebhard DF, Jessen BA, Pennie WD, Will Y
Publikováno v:
Toxicology in vitro : an international journal published in association with BIBRA [Toxicol In Vitro] 2011 Apr; Vol. 25 (3), pp. 715-23. Date of Electronic Publication: 2010 Dec 22.
Autor:
Nadanaciva S; Compound Safety Prediction, Worldwide Medicinal Chemistry, Pfizer Inc., Groton, CT 06340, USA. sashi.nadanaciva@pfizer.com, Dillman K, Gebhard DF, Shrikhande A, Will Y
Publikováno v:
Journal of biomolecular screening [J Biomol Screen] 2010 Sep; Vol. 15 (8), pp. 937-48. Date of Electronic Publication: 2010 Jul 12.
Publikováno v:
Biocell. 2023, Vol. 47 Issue 5, p1051-1063. 13p.